Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Acute Respiratory Failure-II

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pulmonary Cycle: Exhalation

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinical evaluation of the SeptiScore biomarker for the diagnosis of healthcare-associated infections in critically ill trauma patients: a multicenter derivation and validation cohort study.

BMC anesthesiology·2026

Same author

METRNL in bacterial pneumonia, what's new for a new cytokine.

American journal of respiratory cell and molecular biology·2026

Same author

Pulmonary inflammation in severe pneumonia is characterised by compartmentalised and mechanistically distinct sub-phenotypes.

Nature communications·2026

Same author

Reframing sepsis through resistance, disease tolerance and damage: a clinically meaningful conceptual shift?

Intensive care medicine·2026

Same author

Impact of sex on outcomes in critically ill patients with subarachnoid hemorrhage: a secondary analysis of a French prospective cohort study.

Journal of anesthesia, analgesia and critical care·2026

Same author

Longitudinal gut microbiome dynamics are associated with clinical outcome and toxicity during ibrutinib therapy.

Gut microbes·2026

Search research articles

Related Experiment Video

Updated: Dec 1, 2025

Experimental Model to Evaluate Resolution of Pneumonia

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Pulmonary infections complicating ARDS.

Charles-Edouard Luyt^1,2, Lila Bouadma^3,4, Andrew Conway Morris^5,6

¹Service de Médecine Intensive Réanimation, Institut de Cardiologie, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, 47-83, Boulevard de l'Hôpital, 75651, Paris Cedex 13, France. charles-edouard.luyt@aphp.fr.

Intensive Care Medicine

|November 11, 2020

Summary

This summary is machine-generated.

Pulmonary infections are common in acute respiratory distress syndrome (ARDS). While standard and atypical pathogens cause these infections, diagnosis and treatment in ARDS patients remain challenging, necessitating bundled preventive measures.

Keywords:

Acute respiratory distress syndrome Microbiota Nebulization Prevention Ventilator-associated pneumonia

More Related Videos

Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome ARDS

Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome ARDS

Published on: September 7, 2016

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

Related Experiment Videos

Last Updated: Dec 1, 2025

Experimental Model to Evaluate Resolution of Pneumonia

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome ARDS

Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome ARDS

Published on: September 7, 2016

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

Area of Science:

Critical Care Medicine
Infectious Diseases
Pulmonology

Background:

Pulmonary infection is a major complication in acute respiratory distress syndrome (ARDS).
Lung immune defenses and microbiota dysregulation contribute to infection risk in ARDS.
Traditional risk factors are augmented by complex host-pathogen interactions in ARDS.

Purpose of the Study:

To review the challenges in diagnosing and managing pulmonary infections in ARDS patients.
To explore the role of pathogens, diagnostic tools, and treatment strategies for ARDS-associated infections.
To highlight the importance of prevention in high-risk ARDS populations.

Main Methods:

Literature review of pulmonary infections in ARDS.
Analysis of pathogen types, including typical bacteria and atypical organisms.
Discussion of diagnostic challenges and antimicrobial treatment considerations.

Main Results:

ARDS pulmonary infections involve similar bacteria to VAP but also atypical pathogens like Aspergillus, HSV, and CMV.
Diagnosis requires integrated clinical, biological, and microbiological data; modern tools need evaluation.
Antibiotic lung diffusion is a challenge; nebulization and ECMO use present unique issues.

Conclusions:

Diagnosing and treating pulmonary infections in ARDS is complex.
Further evaluation of novel diagnostic tools and targeted therapies is needed.
Strengthening preventive strategies with bundles is the current best approach for ARDS patients.